Thomas L. Muir is the Director of the Venture Development Center at UT Dallas. Mr. Muir holds a Bachelor of Science in Accounting from the University of Utah, and an MBA from Texas Woman’s University. He worked for over 20 years as Treasurer and Controller of United Television, Inc., a publicly traded television broadcasting company, with annual revenue of $325 million. In that role Mr. Muir, managed an investment portfolio worth over $250 million, tightened internal and operating controls, developed forecasting systems for revenue, cash flow, and earnings, managed internal and external financial reporting, including SEC filings, managed employee benefits, and prepared all corporate tax returns.
He negotiated a $75 million revolving credit facility, and co-led a $60 million public subordinated debt offering. Mr. Muir performed due diligence and implementation of financial systems for acquisitions and mergers ranging from $23 million to $5.3 billion. For the past 10 years, Mr. Muir has held various financial positions, including CFO, in a variety of industries, including healthcare insurance, distribution, food service, mortgage banking, real estate development, and public accounting. As an entrepreneur at heart, Mr. Muir enjoys managing the Venture Development Center and nurturing the commercialization of new technologies developed at UT Dallas.
Mr. Schultze graduated cum laude with a B.S. in mechanical engineering from Texas A&M University and in May, 2008, he received his MBA with a concentration in Entrepreneurship from UT-Dallas. He was project manager for a million-dollar process development program at a large semiconductor company and has experience with product development, prototyping, and manufacturing processes. Recent projects include the development of a marketing plan for a trucking security startup and a market analysis of a cutting-edge photonics technology.
Anne Isaac holds a Ph.D. in Microbiology from the Medical College of Wisconsin, where her field of study was characterizing the molecular interactions between a mammalian transcriptional repressor protein and nuclear viral DNA. She continued on to do her post-doctoral research at the McArdle Laboratory for Cancer Research, University of Wisconsin, Madison.
She has several years of experience within the UT system performing evaluations of technologies from diverse disciplines and making patentability recommendations. In her current role as Technology Commercialization Manager she is responsible for securing patent protection and for the commercialization of a portfolio of technologies developed at the University.